STRATA Skin Sciences to Participate in the Benchmark 12th Annual Discovery One-on-One Investor ConferenceGlobeNewsWire • 12/01/23
STRATA Skin Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023GlobeNewsWire • 11/02/23
STRATA Skin Sciences, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 10/31/23
STRATA Skin Sciences to Report Second Quarter 2023 Financial Results on August 9, 2023GlobeNewsWire • 07/28/23
STRATA Skin Sciences Secures additional $12 Million Financing with MidCap FinancialGlobeNewsWire • 07/06/23
STRATA Skin Sciences Appoints Dr. Uri Geiger to Chairman of its Board of DirectorsGlobeNewsWire • 06/30/23
STRATA Skin Sciences Announces First Patients Treated in TheraClear®X Clinical Study for AcneGlobeNewsWire • 05/30/23
STRATA Skin Sciences Announces TheraClear®X Product Demonstration at Music City Scale Symposium for Cosmetic Advances and Laser EducationGlobeNewsWire • 05/19/23
STRATA Skin Sciences Reschedules Fourth Quarter 2022 Conference Call and Webcast to Friday, March 31, 2023GlobeNewsWire • 03/28/23
STRATA Skin Sciences to Report Fourth Quarter 2022 Financial Results on March 28, 2023GlobeNewsWire • 03/14/23
STRATA Skin Sciences Announces TheraClear®X Product Demonstration at Inaugural Winter Clinical ConferenceGlobeNewsWire • 02/16/23